<DOC>
	<DOCNO>NCT02180308</DOCNO>
	<brief_summary>The overarch goal study develop PET/MR technique accurately detect nodal metastasis surgical plan assessment treatment response .</brief_summary>
	<brief_title>Lymph Node Assessment Using Simultaneous 18F-FDG-PET MRI</brief_title>
	<detailed_description>Patients ( n = 30 ) head neck cancer schedule node dissection surgery eligible . Enrolled subject undergo one research PET/MR scan Center Biomedical Imaging ( 660 First Avenue ) within one week prior plan surgery . During dissection , location remove lymph node note term conventional neck lymph node level . PET/MR data use development combine kinetic model analysis PET MRI data ( Aim 1 ) . The final PET/MR finding compare pathological evaluation result order assess accuracy PET/MR detection nodal metastasis ( Aim 2 ) .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Patients head neck cancer schedule node dissection surgery NYU Langone Medical Center Bellevue hospital eligible . Normal MRI exclusion criterion apply , include follow list . A standard MRI safety form use identify potential condition warrant exclusion . Electrical implant cardiac pacemaker perfusion pump Ferromagnetic implant aneurysm clip , surgical clip , prosthesis , artificial heart , valve steel part , metal fragment , shrapnel , bullet , tattoo near eye , steel implant Ferromagnetic object jewelry metal clip clothe Claustrophobia History seizures Diabetes In addition , patient GFR &lt; 15 ml/min/1.73m2 dialysis exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Head cancer</keyword>
	<keyword>Neck cancer</keyword>
	<keyword>MRI</keyword>
	<keyword>PET</keyword>
</DOC>